证券日报网1月6日讯 ，南网数字在接受调研者提问时表示，公司数字基础设施业务应用广泛，以通用 技术平台与底层算力资源为支撑，构建数字化新型基础设施，为大型央国企等提供定制化数字化转型技 术底座。公司将结合募投项目——能源行业数据要素流通交易与服务平台建设项目，持续加强电网数字 基础设施建设，完善云管边端一体化数字基础设施，持续优化南网云，建设"3+1+X"云化数据中心，推 动公有云建设，打造企业级数据湖及统一数据共享服务，加快边缘计算中心建设，满足分布式计算需 求。 （文章来源：证券日报） ...

Core Insights - The article highlights the significant advancements in the integration of AI within the manufacturing sector in Qiantang, Zhejiang Province, showcasing the region's transformation from a manufacturing hub to a strong manufacturing zone through AI-driven initiatives [1][4]. Group 1: AI Applications in Manufacturing - Qiantang has been recognized for its achievements in AI applications, with Zhongce Rubber being named a benchmark enterprise and Hangzhou Youcai Information's AIGC project selected for its high-quality employment initiative [1]. - The region has seen the establishment of three national-level intelligent factories this year, leading the province, and has maintained a strong position in industrial and manufacturing investments [1][3]. - Companies like Xinkong Intelligent are leveraging AI to enhance manufacturing efficiency, providing comprehensive development tools that streamline production processes [2][3]. Group 2: Economic Impact and Growth - The AI manufacturing cluster in Qiantang is projected to generate a value of 28.2 billion yuan in 2024, accounting for 31.1% of the city's total output, with a year-on-year growth of 16.6% in the first nine months of 2025 [3][4]. - The integration of AI in manufacturing has led to significant productivity improvements, exemplified by Zhongce Rubber's record of producing a tire every 3.1 seconds [3]. Group 3: Industry Ecosystem and Innovation - Qiantang's robust industrial ecosystem, with five leading industries contributing over 87% of the output, has created fertile ground for AI applications [4]. - The region is emerging as a hub for AI in biomedicine, with over 1,800 biopharmaceutical companies and numerous top-tier innovation platforms enhancing product development through AI [4][5]. - Companies like Xinbeilai Biotechnology are at the forefront of the "AI + biomedicine" trend, utilizing AI to streamline drug development processes and significantly reduce time and costs [5][6].